Neurocrine Biosciences - Chart of the Day

Neurocrine Biosciences (NBIX) is the Barchart Chart of the Day.  The biological products company has a Trend Spotter buy signal, a Weighted Alpha of 207.60+ and gained 243.53% in the last year.

The Chart of the Day belongs to Neurocrine Biosciences (NBIX).  I found the biological products stock by using Barchart to sort the Russell 3000 Index stocks first for the highest Weighted Alpha, then for technical buy signals of 80% or better.  Next I used the Flipchart featufre to review the charts.  Since the Trend spotter signaled a buy on 9/2 the stock gained 10.68%.

Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.

The status of Barchart's Opinion trading systems are listed below.  Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates.  The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

Barchart technical indicators:

• 80% Barchart technical buy signals
• 207.60+ Weighted Alpha
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 8 new highs and up 14.53% in the last month
• Relative Strength Index 67.63%
• Barchart computes a technical support level at 52.07
• Recently traded at 54.93 with a 50 day moving average of 49.12

Fundamental factors:

• Market Cap $4.58 billion
• Revenue and Earnings projections are very mixed for this stock
• Wall Street analysts issued 3 strong buy and 7 buy recommendations for this stock
• The individual investor on Motley Fool voted 322 to 47 for the stock to beat the market

The best technical trading strategy for this stock has been the price vs. 50 day moving average.